News

Tue, 14/12/2021
Save the date: 2nd Inflammation & Imaging Symposium
Münster. Save the date: 12-14 September 2022! We cordially invite you to join this international symposium, jointly organized by the research networks CRC 1450, CRC 1009, CRC 1348, CRU 342, CRC/TR 128 and the Cells in Motion Interfaculty Centre at the University of Münster. At the same time, we will officially open the new research […]...more
Mon, 09/08/2021
Dietary conjugated linoleic acid links reduced intestinal inflammation to amelioration of CNS autoimmunity
A close interaction between gut immune responses and distant organ-specific autoimmunity including the CNS in multiple sclerosis has been established in recent years. This so-called gut-CNS axis can be shaped by dietary factors, either directly or via indirect modulation of the gut microbiome and its metabolites. Here, SFB 128 PI Luisa Klotz and colleagues report […]...more
Thu, 28/01/2021
BioNTech Publishes Data on Novel mRNA Vaccine Approach to Treat Autoimmune Diseases in Science
BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) announced the publication of preclinical data on its novel mRNA vaccine approach against autoimmune diseases in the peer-reviewed journal Science. The publication titled “A non-inflammatory mRNA vaccine for treatment of experimental autoimmune encephalomyelitis” co-authored by SFB principal investigator Ari Waisman summarizes the findings on the disease-suppressing effects […]...more


Thu, 16/03/2017 | SFB Scientists reprogram skin cells to brain cells to facilitate neurological research

SFB scientists Prof. Tanja Kuhlmann und Dr. Marc Ehrlich generate oligodendrocytes from skin cells (photo: FZ/E. Deiters-Keul)

Münster. (mfm/jr) Whether it be math, writing, reading or learning a new language: brain cells give us astonishing brainpower every day. When these cells are damaged by neurological diseases, cells cannot be simply sampled and analyzed in a petri dish. Scientists from the University of Münster and the Max Planck Institute for Molecular Biomedicine developed a new protocol to generate their brain cells of interest, oligodendrocytes, from skin. The team in Münster belongs to the few labs worldwide that have established this technique successfully in their lab; however the team in Münster can do this now much faster and more efficiently – with significant benefit for research. More .  . .